Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

NUCYNTA EXTENDED-RELEASE

KNIGHT THERAPEUTICS INC.

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of NUCYNTA EXTENDED-RELEASE in Canada?

A shortage of NUCYNTA EXTENDED-RELEASE 250MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 5, 2026), but it has not started yet.

Why is NUCYNTA EXTENDED-RELEASE not available?

The reason the manufacturer reported: Delay in shipping of the drug.

When will NUCYNTA EXTENDED-RELEASE be available again?

The manufacturer's estimated resolution date is November 11, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file4 products
Expected resolution~34 days remaining (estimate)
Affected strength250MG
Last updated2026-10-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

NUCYNTA CR

JANSSEN INC

100MG · DIN 02360381

Different strengthSame dosage formSame routeNo current shortage

NUCYNTA EXTENDED-RELEASE

KNIGHT THERAPEUTICS INC.

50MG · DIN 02415577

Different strengthSame dosage formSame routeNo current shortage

APO-TAPENTADOL

APOTEX INC

50MG · DIN 02471965

Different strengthDifferent dosage formSame routeNo current shortage

NUCYNTA IR

KNIGHT THERAPEUTICS INC.

50MG · DIN 02378272

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2026-11-11

~34 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02415615

Strength

250MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

TAPENTADOL

Tier

Unrated

Last Updated

2026-10-05

Reason for Shortage

Delay in shipping of the drug.

Past Reports for This Drug

NUCYNTA EXTENDED-RELEASE has 2 shortage/discontinuation reports on file — this is one of them.